| Phase II Study of Chidamide, a New Subtype-Selective Oral Histone Deacetylase Inhibitor, in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma | |
| Shi, Yuankai; Dong, Mei; Zhu, Jun; Zhou, Daobin; Huang, Huiqiang; Tu, Ping; Zhang, Weijing; Hong, Xiaonan; Zhao, Xielan; Sun, Jianfang | |
| 2015 | |
| 卷号 | 126 |
| 期号 | 23 |
| 会议录 | BLOOD
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| ISSN号 | 0006-4971 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4643272 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Shi, Yuankai,Dong, Mei,Zhu, Jun,et al. Phase II Study of Chidamide, a New Subtype-Selective Oral Histone Deacetylase Inhibitor, in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论